- Home
- HG vs RXRX Comparison
HG vs RXRX Comparison
Compare HG & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HG | RXRX |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HG | RXRX |
|---|---|---|
| Price | $26.22 | $4.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $29.86 | $7.50 |
| AVG Volume (30 Days) | 442.9K | ★ 24.4M |
| Earning Date | 02-25-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.19 | N/A |
| Revenue | ★ $2,745,461,000.00 | $43,689,000.00 |
| Revenue This Year | $25.37 | $6.74 |
| Revenue Next Year | $0.75 | $34.31 |
| P/E Ratio | $6.30 | ★ N/A |
| Revenue Growth | ★ 21.12 | N/A |
| 52 Week Low | $16.80 | $3.79 |
| 52 Week High | $28.72 | $12.36 |
Technical Indicators
Market Signals| Indicator | HG | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.05 | 53.07 |
| Support Level | $25.53 | $4.61 |
| Resistance Level | $26.67 | $4.98 |
| Average True Range (ATR) | 0.69 | 0.23 |
| MACD | -0.19 | 0.05 |
| Stochastic Oscillator | 25.00 | 65.79 |
Price Performance
Historical ComparisonAbout HG Hamilton Insurance Group Ltd. Class B
Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in London, Dublin, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.